Companies researching Lynparza (Olaparib)
Lynparza (olaparib) is a PARP‑inhibitor medication used as maintenance therapy for adults with advanced ovarian cancer that carries a BRCA mutation.
11
companies
List of companies that research Lynparza (Olaparib)
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United Kingdom | Pharmaceutical Manufacturing | 79k | Lynparza (Olaparib) | ||
United Kingdom | Research Services | 1.6k | $35M | Lynparza (Olaparib) | |
United States | Pharmaceutical Manufacturing | 41k | $10B | Lynparza (Olaparib) | |
United Kingdom | Higher Education | 11k | $716M | Lynparza (Olaparib) |
Showing top companies out of 11 that research Lynparza (Olaparib). Get the full list on TheirStack.
Frequently asked questions



